covid_266 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Theravance Biopharma starts dosing in Phase II Covid-19 study

The drug is meant to address acute lung injury in hospitalised Covid-19 patients. Credit: Masum Ali from Pixabay.